Two patients with obsessive-compulsive disorder experienced an
exacerbation of chronic obsessional doubt after double-blind, placebo-
controlled administration of naloxone. Endogenous opiates may be involved
in the pathogenesis of this symptom.
Subscribe Now/Learn More
Purchase Online access to this article for 24 hours
PsychiatryOnline subscription options offer access to the DSM-IV-TR® library, books,
journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists
and mental health professionals with key resources for diagnosis, treatment, research,
and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing PsychiatryOnline@psych.org
or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).